Men frequently ask whether BPC-157 therapy can raise testosterone levels or enhance the effects of testosterone replacement therapy
Other growth factors such as bone morphogenetic proteins (BMPs) have received FDA approval for specific indications and may represent more appropriate therapeutic choices for conditions where approved therapies are available and indicated
This approach has several problems: interaction effects are completely unknown for most combinations
Some compounds discussed are not FDA-approved for weight management
Turkovic et al., 2004), resistant to L-NAME, even in conditions when L-arginine does not work, which has some physiologic importance (Sikiric et al., 1997
BOTOX, Daxxify, Dysport, & Xeomin BOTOX, Daxxify, and Xeomin are in a class of injectable treatments known as wrinkle relaxers